Dr. Kadota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8001 Frost St
Entrance 10
San Diego, CA 92123Phone+1 858-966-5811Fax+1 858-309-6301
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pediatric Hematology/Oncology, 1980 - 1985
- Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 1979 - 1980
- Northwestern University The Feinberg School of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1985 - 2026
- MN State Medical License 1980 - 2015
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 23 citationsDose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.Richard Kadota, Donald H. Mahoney, John Doyle, Reggie E. Duerst, Henry S. Friedman
Pediatric Blood & Cancer. 2008-11-01 - 4 citationsA pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric...M. Fevzi Ozkaynak, Indira Sahdev, Thomas G. Gross, John E. Levine, Alexandra Cheerva
Journal of Pediatric Hematology/oncology. 2008-03-01 - 24 citationsCyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study.Richard P. Kadota, Larry E. Kun, James W. Langston, Peter C. Burger, Michael E. Cohen
Journal of Pediatric Hematology/oncology. 1999-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: